Global Sanger Sequencing Service Market Size, Status and Forecast 2025

PART 1. INTRODUCTION: SANGER’S SEQUENCING SERVICE MARKET

1.1. REPORT DESCRIPTION

1.2. KEY BENEFITS

1.3. KEY MARKET SEGMENTS

PART 2. GLOBAL SANGER’S SEQUENCING SERVICE MARKET: EXECUTIVE SUMMARY

PART 3. GLOBAL AND REGIONAL MARKET SHARE ANALYIS: SANGER’S SEQUENCING SERVICE MARKET

3.1. GLOBAL SANGER’S SEQUENCING SERVICES MARKET: MARKET SHARE ANALYSIS, 2018

3.2. UNITED STATES SANGER’S SEQUENCING SERVICES MARKET: MARKET SHARE ANALYSIS, 2018

3.3. EU SANGER’S SEQUENCING SERVICES MARKET: MARKET SHARE ANALYSIS, 2018

3.4. JAPAN SANGER’S SEQUENCING SERVICES MARKET: MARKET SHARE ANALYSIS, 2018

3.5. CHINA SANGER’S SEQUENCING SERVICES MARKET: MARKET SHARE ANALYSIS, 2018

3.6. INDIA SANGER’S SEQUENCING SERVICES MARKET: MARKET SHARE ANALYSIS, 2018

3.7. SOUTH-EAST ASIA SANGER’S SEQUENCING SERVICES MARKET: MARKET SHARE ANALYSIS, 2018

3.8. REST OF THE WORLD SANGER’S SEQUENCING SERVICES MARKET: MARKET SHARE ANALYSIS, 2018

PART 4. GLOBAL SANGER’S SEQUENCING SERVICE MARKET: MARKET OVERVIEW

4.1. MARKET SCOPE AND DEFINITION

4.2. COMPETITIVE ENVIRONMENT ANALYSIS

4.2.1. Top investment pockets

4.2.2. Top winning strategies

4.3. TOP PLAYER POSITIONING, 2016

4.4. PATENT ANALYSIS, 2010-2018

4.5. MARKET DYNAMICS

4.5.1. Drivers

4.5.1.1. Technological advancements in Sanger’s sequencing

4.5.1.2. Surge in applications of Sanger’s sequencing

4.5.1.3. Increase in genome mapping programs

4.5.2. Restraints

4.5.2.1. Lack of skilled professionals

4.5.2.2. Standardization concerns over sequencing based diagnostics

4.5.3. Opportunities

4.5.3.1. Cloud computing: a potential data management service

4.5.3.2. Lucrative opportunities in the emerging markets

PART 5. COMPANY PROFILES AND KEY DATA

5.1. CEMIA SA

5.1.1. Company Profile

5.1.2. Main Business/Business Overview

5.1.3. Products, Services, and Solutions

5.1.4. CeMIA Revenue (Million USD)

5.2. FASTERIS SA

5.2.1. Company Profile

5.2.2. Main Business/Business Overview

5.2.3. Products, Services, and Solutions

5.2.4. Fasteris Revenue (Million USD)

5.3. GENEWIZ, INC.

5.3.1. Company Profile

5.3.2. Main Business/Business Overview

5.3.3. Products, Services, and Solutions

5.3.4. GENEWIZ Revenue (Million USD)

5.3.5. Recent Developments

5.4. GENHUNTER CORPORATION

5.4.1. Company Profile

5.4.2. Main Business/Business Overview

5.4.3. Products, Services, and Solutions

5.4.4. GenHunter Revenue (Million USD)

5.5. GENSCRIPT BIOTECH CORPORATION

5.5.1. Company Profile

5.5.2. Main Business/Business Overview

5.5.3. Products, Services, and Solutions

5.5.4. GenScript Revenue (Million USD)

5.6. LGC SCIENCE GROUP HOLDINGS LIMITED

5.6.1. Company Profile

5.6.2. Main Business/Business Overview

5.6.3. Products, Services, and Solutions

5.6.4. LGC Revenue (Million USD)

5.6.5. Recent Developments

5.7. MICROSYNTH AG

5.7.1. Company Profile

5.7.2. Main Business/Business Overview

5.7.3. Products, Services, and Solutions

5.7.4. Microsynth Revenue (Million USD)

5.8. NUCLEICS PTY. LTD.

5.8.1. Company Profile

5.8.2. Main Business/Business Overview

5.8.3. Products, Services, and Solutions

5.8.4. Nucleics Revenue (Million USD)

5.9. QUINTARA BIOSCIENCES

5.9.1. Company Profile

5.9.2. Main Business/Business Overview

5.9.3. Products, Services, and Solutions

5.9.4. Quintara Revenue (Million USD)

5.9.5. Recent Developments

5.10. SCIGENOM LABS PVT. LTD

5.10.1. Company Profile

5.10.2. Main Business/Business Overview

5.10.3. Products, Services, and Solutions

5.10.4. SciGenom Labs Revenue (Million USD)

5.11. SOURCE BIOSCIENCE PLC

5.11.1. Company Profile

5.11.2. Main Business/Business Overview

5.11.3. Products, Services, and Solutions

5.11.4. Source BioScience Revenue (Million USD)

5.12. THERMO FISHER SCIENTIFIC INC.

5.12.1. Company Profile

5.12.2. Main Business/Business Overview

5.12.3. Products, Services, and Solutions

5.12.4. Thermo Fisher Revenue (Million USD)

5.12.5. Recent Developments

PART 6. GLOBAL SANGER’S SEQUENCING SERVICE MARKET: MARKET BY APPLICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. DIAGNOSTICS

6.2.1. Market size and forecast, by region

6.2.2. Market analysis, by region

6.3. BIOMARKERS & CANCER

6.3.1. Market size and forecast, by region

6.3.2. Market analysis, by region

6.4. REPRODUCTIVE HEALTH

6.4.1. Market size and forecast, by region

6.4.2. Market analysis, by region

6.5. PERSONALIZED MEDICINE

6.5.1. Market size and forecast, by region

6.5.2. Market analysis, by region

6.6. FORENSICS

6.6.1. Market size and forecast, by region

6.6.2. Market analysis, by region

6.7. OTHER APPLICATIONS

6.7.1. Market size and forecast, by region

6.7.2. Market analysis, by region

PART 7. GLOBAL SANGER’S SEQUENCING SERVICE MARKET: MARKET BY END USER

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. ACADEMIC & GOVERNMENT RESEARCH INSTITUTES

7.2.1. Market size and forecast, by region

7.2.2. Market analysis, by region

7.3. PHARMACEUTICAL COMPANIES

7.3.1. Market size and forecast, by region

7.3.2. Market analysis, by region

7.4. BIOTECHNOLOGY COMPANIES

7.4.1. Market size and forecast, by region

7.4.2. Market analysis, by region

7.5. HOSPITALS & CLINICS

7.5.1. Market size and forecast, by region

7.5.2. Market analysis, by region

PART 8. GLOBAL SANGER’S SEQUENCING SERVICE MARKET: MARKET BY REGION

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. UNITED STATES

8.2.1. Key market trends

8.2.2. United States market size and forecast

8.2.2.1. United States Sanger’s Sequencing Service Market by application

8.2.2.2. United States Sanger’s Sequencing Service Market, by end user

8.3. EU

8.3.1. Key market trends

8.3.2. EU market size and forecast

8.3.2.1. EU Sanger’s Sequencing Service Market by application

8.3.2.2. EU Sanger’s Sequencing Service Market, by end user

8.4. JAPAN

8.4.1. Key market trends

8.4.2. Japan market size and forecast

8.4.2.1. Japan Sanger’s Sequencing Service Market by application

8.4.2.2. Japan Sanger’s Sequencing Service Market, by end user

8.5. CHINA

8.5.1. Key market trends

8.5.2. China market size and forecast

8.5.2.1. China Sanger’s Sequencing Service Market by application

8.5.2.2. China Sanger’s Sequencing Service Market, by end user

8.6. INDIA

8.6.1. Key market trends

8.6.2. India market size and forecast

8.6.2.1. India Sanger’s Sequencing Service Market by application

8.6.2.2. India Sanger’s Sequencing Service Market, by end user

8.7. SOUTH-EAST ASIA

8.7.1. Key market trends

8.7.2. South-East Asia market size and forecast

8.7.2.1. South-East Asia Sanger’s Sequencing Service Market by application

8.7.2.2. South-East Asia Sanger’s Sequencing Service Market, by end user

8.8. REST OF THE WORLD

8.8.1. Key market trends

8.8.2. Rest of the world market size and forecast

8.8.2.1. Rest of the world Sanger’s Sequencing Service Market by application

8.8.2.2. Rest of the world Sanger’s Sequencing Service Market, by end user

PART 9. CONCLUSION: SANGER’S SEQUENCING SERVICE MARKET

PART 10. DATA SOURCE AND METHODOLOGY

10.1. RESEARCH APPROACH AND METHODOLOGY

10.1.1. Research Programs/Design

10.1.1.1. Market Size Estimation

10.1.1.2. Market Breakdown and Data Triangulation

10.1.2. Data Source

10.1.2.1. Secondary sources

10.1.2.2. Primary Sources

List of Tables

TABLE 1. CEMIA: COMPANY SNAPSHOT

TABLE 5. GENSCRIPT: COMPANY SNAPSHOT

TABLE 7. MICROSYNTH: COMPANY SNAPSHOT

TABLE 12. THERMO FISHER: COMPANY SNAPSHOT

TABLE 13. GLOBAL SANGER’S SEQUENCING SERVICE MARKET, BY APPLICATION, 2013–2025 ($MILLION)

TABLE 14. SANGER’S SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, BY REGION, 2013–2025 ($MILLION)

TABLE 15. SANGER’S SEQUENCING SERVICE MARKET FOR DIAGNOSTICS, BY REGION, 2013–2025 ($MILLION)

TABLE 16. SANGER’S SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2013–2025 ($MILLION)

TABLE 17. SANGER’S SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2013–2025 ($MILLION)

TABLE 18. SANGER’S SEQUENCING SERVICE MARKET FOR FORENSICS, BY REGION, 2013–2025 ($MILLION)

TABLE 19. SANGER’S SEQUENCING SERVICE MARKET FOR OTHER APPLICATIONS, BY REGION, 2013–2025 ($MILLION)

TABLE 20. GLOBAL SANGER’S SEQUENCING SERVICE MARKET, BY END USER, 2013–2025 ($MILLION)

TABLE 21. SANGER’S SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013–2025 ($MILLION)

TABLE 22. SANGER’S SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2013–2025 ($MILLION)

TABLE 23. SANGER’S SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2013–2025 ($MILLION)

TABLE 24. SANGER’S SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2013–2025 ($MILLION)

TABLE 25. SANGER’S SEQUENCINGSERVICE MARKET, BY REGION,  2013–2025 ($MILLION)

TABLE 26. UNITED STATES SANGER’S SEQUENCING SERVICE MARKET,  BY APPLICATION, 2013–2025 ($MILLION)

TABLE 27. UNITED STATES SANGER’S SEQUENCING SERVICE MARKET,  BY END USER, 2013–2025 ($MILLION)

TABLE 28. EU SANGER’S SEQUENCING SERVICE MARKET,  BY APPLICATION, 2013–2025 ($MILLION)

TABLE 29. EU SANGER’S SEQUENCING SERVICE MARKET, BY END USER, 2013–2025 ($MILLION)

TABLE 30. JAPAN SANGER’S SEQUENCING SERVICE MARKET, BY APPLICATION, 2013–2025 ($MILLION)

TABLE 31. JAPAN SANGER’S SEQUENCING SERVICE MARKET, BY END USER, 2013–2025 ($MILLION)

TABLE 32. CHINA SANGER’S SEQUENCING SERVICE MARKET, BY APPLICATION, 2013–2025 ($MILLION)

TABLE 33. CHINA SANGER’S SEQUENCING SERVICE MARKET, BY END USER, 2013–2025 ($MILLION)

TABLE 34. INDIA SANGER’S SEQUENCING SERVICE MARKET, BY APPLICATION, 2013–2025 ($MILLION)

TABLE 35. INDIA SANGER’S SEQUENCING SERVICE MARKET, BY END USER, 2013–2025 ($MILLION)

TABLE 36. SOUTH-EAST ASIA SANGER’S SEQUENCING SERVICE MARKET, BY APPLICATION, 2013–2025 ($MILLION)

TABLE 37. SOUTH-EAST ASIA SANGER’S SEQUENCING SERVICE MARKET, BY END USER, 2013–2025 ($MILLION)

TABLE 38. REST OF THE WORLD SANGER’S SEQUENCING SERVICE MARKET, BY APPLICATION, 2013–2025 ($MILLION)

TABLE 39. REST OF THE WORLD SANGER’S SEQUENCING SERVICE MARKET, BY END USER, 2013–2025 ($MILLION)

List of Figures

FIGURE 1. GLOBAL SANGER’S SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2018

FIGURE 2. UNITED STATES SANGER’S SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2018

FIGURE 3. EU SANGER’S SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2018

FIGURE 4. JAPAN SANGER’S SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2018

FIGURE 5. CHINA SANGER’S SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2018

FIGURE 6. INDIA SANGER’S SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2018

FIGURE 7. SOUTH-EAST ASIA SANGER’S SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2018

FIGURE 8. REST OF THE WORLD SANGER’S SEQUENCING SERVICE MARKET: MARKET SHARE ANALYSIS, 2018

FIGURE 9. GLOBAL SANGER’S SEQUENCING SERVICE MARKET SEGMENTATION

FIGURE 10. TOP INVESTMENT POCKETS: GLOBAL SANGER’S SEQUENCING SERVICE MARKET SEGMENTATION

FIGURE 14. TOP PLAYER POSITIONING, 2016: SANGER’S SEQUENCING SERVICE MARKET

FIGURE 15. PATENT ANALYSIS, BY YEAR

FIGURE 16. PATENT ANALYSIS, BY REGION

FIGURE 17. IMPACT ANALYSES: GLOBAL SANGER’S SEQUENCING SERVICE MARKET

FIGURE 27. MARKET SEGMENTATION, BY APPLICATION: GLOBAL SANGER’S SEQUENCING SERVICE MARKET

FIGURE 28. COMPARATIVE REGION ANALYSIS OF SANGER’S SEQUENCING SERVICE MARKET FOR DIAGNOSTICS , 2013 AND 2025 ($MILLION)

FIGURE 29. COMPARATIVE REGION ANALYSIS OF SANGER’S SEQUENCING SERVICE MARKET FORBIOMARKERS & CANCER, 2013 AND 2025 ($MILLION)

FIGURE 30. COMPARATIVE REGION ANALYSIS OF SANGER’S SEQUENCING SERVICE MARKET FOR REPRODUCTIVE HEALTH, 2013 AND 2025 ($MILLION)

FIGURE 31. COMPARATIVE REGION ANALYSIS OF SANGER’S SEQUENCING SERVICE MARKET FOR PERSONALIZED MEDICINE,  2013 AND 2025 ($MILLION)

FIGURE 32. COMPARATIVE REGION ANALYSIS OF SANGER’S SEQUENCING SERVICE MARKET FOR FORENSICS, 2013 AND 2025 ($MILLION)

FIGURE 33. COMPARATIVE REGION ANALYSIS OF SANGER’S SEQUENCING SERVICE MARKET FOR OTHER APPLICATIONS, 2013 AND 2025 ($MILLION)

FIGURE 34. COMPARATIVE REGION ANALYSIS OF SANGER’S SEQUENCING SERVICE MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, 2013 AND 2025 ($MILLION)

FIGURE 35. COMPARATIVE REGION ANALYSIS OF SANGER’S SEQUENCING SERVICE MARKET FOR PHARMACEUTICAL COMPANIES, 2013 AND 2025 ($MILLION)

FIGURE 36. COMPARATIVE REGION ANALYSIS OF SANGER’S SEQUENCING SERVICE MARKET FOR BIOTECHNOLOGY COMPANIES, 2013 AND 2025 ($MILLION)

FIGURE 37. COMPARATIVE REGION ANALYSIS OF SANGER’S SEQUENCING SERVICE MARKET FOR HOSPITALS & CLINICS, 2013 AND 2025 ($MILLION)

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.